| mRNA |
1S,3R-RSL-3 |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
2e-06 |
| mRNA |
PD-0325901 |
GDSC1000 |
pan-cancer |
AAC |
0.14 |
1e-05 |
| mRNA |
TG-101348 |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
2e-05 |
| mRNA |
ML162 |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
6e-05 |
| mRNA |
17-AAG |
GDSC1000 |
pan-cancer |
AAC |
0.12 |
0.0002 |
| mRNA |
prima-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0002 |
| mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.0002 |
| mRNA |
PX-12 |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.0003 |
| mRNA |
CCT036477 |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0003 |
| mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0004 |